에 대한 최신 뉴스 Estee Lauder Cos (NYSE:EL) 주식

ESTEE LAUDER COMPANIES-CL A

Estee Lauder Cos

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.

paypal-shutter2

Equities

Large Cap

News

Movers

Trading Ideas

AVTR

ILMN

MRNA

NBIX

PYPL

SWKS

이들 10개 대형주는 지난 주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 스카이웍스 솔루션(NASDAQ:SWKS)의 주식은 회사가 1분기 실적을 발표하고 2분기 가이던스를 예상치 이하로 제시한 후 25.99% 하락했다. 애널리스트들은 주가 전망을 수정했다.

에스티 로더, 모더나 및 페이팔 등 지난주 하락한 10개의 대형주 (2월 3일-7일)

Bangkok,,Thailand,-,November,20,,2020,:,Estee,Lauder,Store

Technicals

에스티 로더 컴퍼니즈(NYSE:EL) 주식은 금요일에 소폭 하락했지만 최근 상승세는 유지되고 있다. 만약 주가가 83.00달러에 도달하면 저항선을 만날 가능성이 높다. 아래 차트에서 볼 수 있듯이, 12월에 83.00달러 근처에서 저항선이 있었다. 이 때문에 오늘의 주식으로 선정했다.

오늘의 주식: 구매자의 후회가 에스티 로더 주식의 거래 기회를 조성

LiAuto.Shutterstock

APTV

BORR

CHKP

MPWR

SMCI

이들 10개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 슈퍼 마이크로 컴퓨터(NASDAQ:SMCI)의 주식은 독립 감사인인 언스터 &amp; 영(Ernst &amp; Young)의 사임 소식이 전해진 후 44.89% 하락했다. 아거스 리서치(Argus Research)는 매수에서 보유로 등급을 하향 조정했다.

슈퍼 마이크로 및 에스티 로더는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (10월 28일-11월 1일)

Estee Lauder Companies, Inc. (The) Common Stock

The Estee Lauder Companies Inc

ELYSIA

Envela Corp

Elastos - United States Dollar

PMGC Holdings Inc

ELATE HLDGS LTD PCL by ELATE HLDGS LTD PUBLIC COMPANY LIMITED

Elate Holdings Ltd

EL AL ISRAEL AIRLS LTD by EL AL Israel Airlines Ltd.

El AL Israel Airlines Ltd

ELAMEX S.A. DE C.V. by Elamex S.A. de C.V.

Elamex SA de CV

Elanco Animal Health Incorporated Common Stock

Elanco Animal Health Inc

ELBIT MEDICAL TECHS by Elbit Medical Technologies Ltd

Elbit Medical Technologies Ltd

Electra Battery Materials Corporation - Common Stock

Electra Battery Materials Corp

Entergy Louisiana, Inc. Collateral Trust Mortgage Bonds, 4.875 % Series due September 1, 2066

ELECO HOLDINGS PLC by ELECO HOLDINGS PLC

ELECTRA STONE LTD ORD by Electra Stone Ltd

Electra Stone Ltd

Elecom Co Ltd

ELCOM INTL INC by Elcom International, Inc.

Elcom International Inc

EDP-Energias De Portugal SA

ELECTRIC CAR CO INC by Electric Car Company, Inc.

Electric Car Co Inc

Strategy Shares Eventide High Dividend ETF

WisdomTree Emerging Markets Local Debt Fund

ELECTRUM DISCOVERY CORP by ELECTRUM DISCOVERY CORP.

Electrum Discovery Corp

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

El.En. SpA

ELECTRIC ROYALTIES LTD by Electric Royalties Ltd.

Electric Royalties Ltd

ELEMENT FLEET MGMT CORP by Element Fleet Mgmt Corp.

Element Fleet Management Corp

Elektros Inc

ELEMENTAL ALTUS ROYALTIES by ELEMENTAL ALTUS ROYALTIES CORP.

Elemental Altus Royalties Corp

Elevation Oncology Inc

Endesa SA

e.l.f. Beauty Inc

aelf

E-L Financial Corp Ltd

ALPS Electrification Infrastructure ETF

ELEMENT GLOBAL INC by Element Global, Inc.

Element Global Inc

ELECTRIC & GAS TECH INC by Electric & Gas Technology, Inc.

ELIA SYSTEM OPERATOR SA by Elia System Operator SA/NV

Elia Group SA/NV

Direxion Daily LLY Bull 2X Shares

Elio Motors Inc

ELECTRIQ POWER HLDGS A by Electriq Power Holdings Inc.

Electriq Power Holdings Inc

Electriq Power Holdings Inc Warrants (25/01/2028)

Direxion Daily LLY Bear 1X Shares

Elixxer Ltd

Elkem ASA

GOLD ROAD RES LTD ORD by Gold Road Resources Ltd.

Gold Road Resources Ltd

Elah Holdings Inc

Ellaktor SA

Ellomay Capital Ltd Ordinary Shares (Israel)

Ellomay Capital Ltd

ELRINGKLINGER AG UNSP/ADR by Elringklinger Ag

ElringKlinger AG

Elixinol Wellness Ltd Ordinary Shares

ELIXINOL WELLNESS LTD by Elixinol Wellness Ltd.

Elixinol Wellness Ltd

Series Portfolios Trust Elm Market Navigator ETF

Elmer Bancorp Inc

Electromed Inc

Elme Communities

Element79 Gold Corp

ELEMENT79 GOLD CORP by Element79 Gold Corp.

Elemon

ELECTRIC LAST MILE SOLN A by Electric Last Mile Solutions Inc.

Electric Last Mile Solutions Inc

Element 25 Ltd

Elementis PLC

Elisa Oyj

Electric Last Mile Solutions Inc Warrants (24/06/2026)

ELANIX BIOTECHNOLOGIES AG by ELANIX BIOTECHNOLOGIES AG

Elecnor SA

Element Nutritional Sciences Inc Ordinary Shares

Elinx Corp

EMERGENCE GLOBAL ENTRPSE by EMERGENCE GLOBAL ENTERPRISES INC.

Emergence Global Enterprises Inc

Tidal Trust III Battleshares TSLA vs F ETF

Dogelon Mars

Elior Group SA

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals Inc

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)

Cia Paranaense De Energia Copel

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing four (4) Common Shares)

Elopak ASA

EL PUERTO LIVERPOOL SHS 1 by El Puerto de Liverpool S.A. de C.V.

El Puerto de Liverpool SAB de CV

Elong Power Holding Limited - Class A Ordinary Shares

Elong Power Holding Ltd

iShares ESG Advanced Investment Grade Corporate Bond ETF

ELRAY RESOURCES INC by Elray Resources, Inc.

Elray Resources Inc

Yinfu Gold Corp

EASTERN PLATINUM LTD NEW by Eastern Platinum Ltd.

Eastern Platinum Ltd

ELRON VENTURES LTD by Elron Ventures Ltd.

Elron Ventures Ltd

ELORO RESOURCES LTD by Eloro Resources Ltd.

Eloro Resources Ltd

AKTIEBOLAGET ELECTROLUX B by AB Electrolux

Electrolux AB

Equity Lifestyle Properties, Inc. Common Stock

Equity Lifestyle Properties Inc

Electro-Sensors Inc

Elis SA

ELECTRONIC SYS TECHNOLOGY by Electronic Systems Technology, Inc.

Electronic Systems Technology Inc

Eltek Ltd

Elementos Ltd

ELITE PHARMS INC by Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Inc

ELMOS SEMICONDUCTOR AG by Elmos Semiconductor AG

Elmos Semiconductor SE

Elicio Therapeutics Inc

Elutia Inc

UBS analyst Peter Grom maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and raises the price target from $60 to $62.

Price Target

Analyst Ratings

UBS Maintains Neutral on Estee Lauder Cos, Raises Price Target to $62

Telsey Advisory Group analyst Dana Telsey <a target="_blank" href="https://www.benzinga.com/quote/EL/analyst-ratings" rel="noreferrer noopener">reiterated a Market Perform</a> rating on the shares of Estée Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) and lowered the price forecast from $76.00 to $66.00.
Estée Lauder delivered a <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45135378/estee-lauder-restructures-slashes-outlook-as-2600-jobs-get-cut" rel="noreferrer noopener">strong third-quarter earnings</a> beat, driven by improved margins and cost control, with sales at the upper end of guidance.
The company updated its FY25 outlook in line with prior estimates, though fourth-quarter EPS guidance came in below expectations.
While its recovery plan is yielding positive results, ongoing pressures in Asia travel retail and a softening North American market prompt a reduced price target of $66.
EL is adapting to trade policy uncertainty by regionalizing its supply chain to increase flexibility. About 75% of U.S. sales are now sourced domestically or through trade agreements, while reliance on China is being reduced in favor of Japan and Europe.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/05/45166629/wendys-q1-misses-revenue-estimate-lowers-2025-outlook-amid-us-sales-dip" rel="noreferrer noopener">Wendy's Sizzles Abroad, But US Sales Leave Investors Cold</a>
The company is also optimizing manufacturing and local sourcing to mitigate risks. No major FY25 impact is expected, but prolonged tariffs could affect FY26. More updates are expected in August, noted the analyst.
Estée Lauder brands are showing positive momentum, with Clinique leading U.S. market share gains for the 11th straight quarter.
The company gained market share in three of four categories, with EL ranking top two in skincare and makeup. MAC and The Ordinary also improved.
In China, multiple brands saw growth across all categories. While some emerging markets faced setbacks, trends are stable overall, with stronger performance expected in FY26.
Factoring in the third-quarter results and current trends in the business, the analyst expects total reported sales to decline 8.5% YoY to $14.29 billion (from down 6.8% to $14.54 billion previously).
In addition, on the bottom line, the analyst raised the FY25 EPS estimate to $1.55, up from $1.36 previously.
Estée Lauder CEO Stéphane de La Faverie reaffirmed the company's "Beauty Reimagined" strategy during its third-quarter earnings call, highlighting early progress on five core priorities: expanding consumer reach, driving innovation, increasing marketing investments, enhancing efficiency, and rethinking operations.
Price Action: EL shares closed higher by 0.85% to $59.39 on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45170433/kimberly-clark-commits-2b-to-us-expansion-overhaul" target="_blank" rel="noreferrer noopener">Kimberly-Clark Commits $2 Billion For US Expansion Overhaul</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Reiteration

General

Estée Lauder's Beauty Gains Can't Offset Global Headwinds, Says Analyst

RBC Capital analyst Nik Modi maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Outperform and lowers the price target from $100 to $90.

RBC Capital Maintains Outperform on Estee Lauder Cos, Lowers Price Target to $90

B. Riley Securities analyst Anna Glaessgen reiterates Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Neutral and lowers the price target from $70 to $60.

B. Riley Securities Reiterates Neutral on Estee Lauder Cos, Lowers Price Target to $60

Piper Sandler analyst Korinne Wolfmeyer reiterates Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Overweight and lowers the price target from $92 to $75.

Piper Sandler Reiterates Overweight on Estee Lauder Cos, Lowers Price Target to $75

Telsey Advisory Group analyst Dana Telsey maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Market Perform and lowers the price target from $76 to $66.

Telsey Advisory Group Maintains Market Perform on Estee Lauder Cos, Lowers Price Target to $66

Across the recent three months, 16 analysts have shared their insights on Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $70.19, a high estimate of $81.00, and a low estimate of $55.00. This current average represents a 7.95% decrease from the previous average price target of $76.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1746108039_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Estee Lauder Cos by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$62.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$60.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Christopher Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Filippo Falorni</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$61.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$67.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$64.00</td>
<td>$71.00</td>
</tr>
<tr>
<td>Linda Bolton Weiser</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Mark Astrachan</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$77.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Hold</td>
<td>$70.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$76.00</td>
<td>$76.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Estee Lauder Cos. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Estee Lauder Cos compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Estee Lauder Cos's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Estee Lauder Cos's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/EL/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Estee Lauder Cos analyst ratings.</a>
<h2>About Estee Lauder Cos</h2>
Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific. Estee Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
<h3>Estee Lauder Cos: Financial Performance Dissected</h3>
Market Capitalization Highlights: Above the industry average, the company's market capitalization signifies a significant scale, indicating strong confidence and market prominence.
Negative Revenue Trend: Examining Estee Lauder Cos's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -6.43% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Estee Lauder Cos's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -14.74%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Estee Lauder Cos's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -12.75%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -2.87%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.25, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Estee Lauder Cos Stock: Analyst Perspectives (16 Ratings)

Estee Lauder Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) shares are trading lower in the premarket session on Thursday after the company <a href="https://www.benzinga.com/pressreleases/25/05/b45128212/the-est-e-lauder-companies-reports-fiscal-2025-third-quarter-results" target="_blank" rel="noreferrer noopener">reported the third-quarter results.</a>
The company reported adjusted earnings per share of 65 cents, beating the analyst consensus estimate of 32 cents. Quarterly sales of $3.55 billion (down 10% year over year) outpaced the street view of $3.52 billion. &nbsp;Organic net sales decreased 9%.
Estée Lauder reported a decline across all product categories:
<ul>
<li>Skin Care sales dropped 11%, mainly due to weaker performance in Asia travel retail, impacting Estée Lauder and La Mer.</li>
<li>Makeup sales fell 7%, largely from lower shipments and fewer new launches at M·A·C.</li>
<li>Fragrance sales dipped 1%, with Clinique contributing to the decline.</li>
<li>Hair Care sales declined 10%, led by softness in Aveda's salon and standalone store channels.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/45115660/3-stocks-to-turn-tariffs-into-opportunities" rel="noreferrer noopener">3 Stocks To Turn Tariffs Into Opportunities</a>
Quarterly gross profit slumped 6% year over year to $2.661 billion. Adjusted gross margin, however, expanded to 75% from 71.9% in the year-ago period. The firm said no significant negative effects are expected from current tariffs, including on consumer sentiment.
Adjusted operating income in the quarter under review slumped 27% year over year to $403 million, with adjusted operating margin contracting to 11.4% from 14.1% in the year-ago period.
The company said that the margin contraction reflects the increase in consumer-facing investments, along with sales volume deleverage in the fiscal 2025 third quarter.
Estée Lauder expanded its Profit Recovery and Growth Plan (PRGP) in February 2025 to boost efficiency, return to sales growth, and restore strong margins by 2027.
The company said it has already improved its adjusted gross margin by over 300 basis points each quarter of fiscal 2025, despite lower sales. Key actions include cutting excess inventory, reducing promotions, and streamlining operations. The restructuring part of the plan involves up to $1.6 billion in charges and a workforce reduction of 5,800 to 7,000 roles. As of April 2025, $623 million in initiatives and over 2,600 job cuts have been approved.
Dividend: The company announced a quarterly dividend of $.35 per share on its Class A and Class B common stock, payable in cash on June 16, to stockholders of record at the close of business on May 30.
Outlook: Estée Lauder lowered its FY2025 adjusted EPS guidance from $2.75–$2.95 to $1.30–$1.55 versus the $1.40 estimate.
It also cut its sales forecast from $15.45 billion–$15.92 billion to $14.20 billion–$14.36 billion, below the $14.51 billion estimate.
Price Action: EL shares are trading higher by 0.73% in the pre-market session, at $60.40 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/05/45133096/this-is-how-much-it-will-cost-general-motors-from-trumps-tariff-policy" target="_blank" rel="noreferrer noopener">This Is How Much It Will Cost General Motors From Trump&#8217;s Tariff Policy</a></li>
</ul>
Image: Shutterstock

Earnings

Guidance

Markets

Estée Lauder Slashes Outlook, Cuts 2,600 Jobs

Telsey Advisory Group analyst Dana Telsey maintains Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) with a Market Perform and maintains $76 price target.

Telsey Advisory Group Maintains Market Perform on Estee Lauder Cos, Maintains $76 Price Target

Macro Economic Events

Rumors

Economics

Watching Estee Lauder; CFO In Conference Call Reportedly Say Company Expects High Rate Of Tariffs To Impact FY26

Watching Estee Lauder; Hearing CFO In Conference Call Reportedly Say Company Is Looking For Ways To Save Due To Heightened Macro And Geopolitical Volatility

WIIM

EL stock has given up its prior gain. Estee Lauder shares were trading higher after the company reported better-than-expected Q3 financial results.

Estee Lauder shares are trading higher after the company reported better-than-expected Q3 financial results.

Estee Lauder Sees FY25 Adj EPS Of $1.30 - $1.55 Vs. $1.4 Est.

Estee Lauder Sees FY25 Net Sales To Decline 9% - 8%

Estee Lauder Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.32 by 103.13 percent. This is a 32.99 percent decrease over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $3.55 billion which beat the analyst consensus estimate of $3.52 billion by 0.92 percent. This is a 9.90 percent decrease over sales of $3.94 billion the same period last year.

Comments

Estee Lauder Cos

뉴스

에 대한 최신 뉴스 Estee Lauder Cos (NYSE:EL) 주식

일요일, 2월 09, 2025

금요일, 1월 17, 2025

일요일, 11월 03, 2024

월요일, 8월 19, 2024

월요일, 7월 01, 2024

수요일, 4월 17, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌